2,2-Dimethyl-4-oxo-3,8,11,14,17,20-hexaoxa-5-azadocosan-22-oic acid

Catalog No. :
ACTXFP219
CAS No. :
890152-41-7
Molecular Formula :
C17H33NO9
Molecular Weight :
395.45

IUPAC Name:2,2-dimethyl-4-oxo-3,8,11,14,17,20-hexaoxa-5-azadocosan-22-oic acid

2,2-Dimethyl-4-oxo-3,8,11,14,17,20-hexaoxa-5-azadocosan-22-oic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$55.00Login to see priceIn stockInquiry
5g98%$274.00Login to see priceIn stockInquiry
10g98%$465.00Login to see priceIn stockInquiry
25g98%$930.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2-Dimethyl-4-oxo-3,8,11,14,17,20-hexaoxa-5-azadocosan-22-oic acid
IUPAC Name2,2-dimethyl-4-oxo-3,8,11,14,17,20-hexaoxa-5-azadocosan-22-oic acid
MDL No.MFCD31656900
Molecular FormulaC17H33NO9
Molecular Weight395.45
SMILESOC(COCCOCCOCCOCCOCCNC(OC(C)(C)C)=O)=O
InChI KeyOLLNIAGWMCSEJB-UHFFFAOYSA-N
Synonym2,2-Dimethyl-4-oxo-3,8,11,14,17,20-hexaoxa-5-azadocosan-22-oic acid, Boc-NH-PEG5-CH2COOH
CAS No.890152-41-7
PubChem CID138393105

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACTXFP219 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTXFP219 route product structure diagram
    ACTXFP219890152-41-7 In Stock
Inquiry

2. ACTXFP219 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYGAH623 route compound structure diagram
    ACYGAH623141282-35-1 In Stock
  4. Then
  5. ACTXFP219 route product structure diagram
    ACTXFP219890152-41-7 In Stock
Inquiry

Comments (0)